Nevertheless, the studied fluid biomarker stages, both in CSF and plasma, showed a good degree of concordance with underlying AD hallmarks and a relevant stratification of the AD continuum into minimal or non-existent, early-to-mid, and advanced tau pathology determined with tau-PET. Here, MAPT is linked to Alzheimer disease.